• Recent news

  • Biotec Pharmacon ASA appoints Dr. Jethro Holter as interim CEO

    (Tromsø/Oslo 23. October 2019) Biotec Pharmacon ASA (OSE: “BIOTEC”) announced today that its Board of Directors has unanimously appointed Dr Jethro Holter as the Company’s interim Chief Executive Officer. Jethro, who currently serves as the Managing Director of ArcticZymes AS, a subsidiary of Biotec Pharmacon, will succeed Christian Jorgensen, the current CEO,…

    Continue reading

Latest presentation

Third quarter 2019 results

Tromsø, Norway, 24 October 2019 – Biotec Pharmacon (OSE: Biotec) announces its third quarter and first nine months 2019 results. Highlights for Q3 2019 and the first nine months: • Group sales marginally up from last year to NOK 22.5 million (Q3 2018: NOK 22.1 million). • Gross profit for the Group improved 8% to NOK…

View more